The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results
Open accessAbstract
Importance: Extracranial carotid and vertebral artery dissection is an important cause of stroke, particularly in younger individuals. In some but not all observational studies, it has been associated with a high risk of recurrent stroke. Both antiplatelet agents (APs) and anticoagulants (ACs) are used to reduce stroke risk, but whether 1 treatment strategy is more effective is unknown. Objective: To determine whether AP or AC therapy is more effective in preventing stroke in cervical dissection and the risk of recurrent stroke in a randomized clinical trial setting. A secondary outcome was to determine the effect on arterial imaging outcomes. Design, Setting, and Participants: Randomized, prospective, open-label international multicenter parallel design study with central blinded review of both clinical and imaging end points. Recruitment was conducted in 39 stroke and neurology secondary care centers in the United Kingdom and 7 centers in Australia between February 24, 2006, and June 17, 2013. One-year follow-up and analysis was conducted in 2018. Two hundred fifty participants with extracranial carotid and vertebral dissection with symptom onset within the last 7 days were recruited. Follow-up data at 1 year were available for all participants. Interventions: Randomization to AP or AC (heparin followed by warfarin) for 3 months, after which the choice of AP and AC agents was decided by the local clinician. Main Outcomes and Measures: The primary end point was ipsilateral stroke and death. A planned per protocol (PP) analysis was performed in patients meeting the inclusion criteria following central review of imaging to confirm the diagnosis of dissection. A secondary end point was angiographic recanalization in those with imaging confirmed dissection. Results: Two hundred fifty patients were randomized (118 carotid and 132 vertebral), 126 to AP and 124 to AC. Mean (SD) age was 49 (12) years. Mean (SD) time to randomization was 3.65 (1.91) days. The recurrent stroke rate at 1 year was 6 of 250 (2.4%) on ITT analysis and 5 of 197 (2.5%) on PP analysis. There were no significant differences between treatment groups for any outcome. Of the 181 patients with confirmed dissection and complete imaging at baseline and 3 months, there was no difference in the presence of residual narrowing or occlusion between those receiving AP (n = 56 of 92) vs those receiving AC (n = 53 of 89) (P = .97). Conclusions and Relevance: During 12 months of follow-up, the number of recurrent strokes was low. There was no difference between treatment groups in outcome events or the rate of recanalization. Trial Registration: ISRCTN.com Identifier: CTN44555237.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCHULMAN, S., & KEARON, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01204.x · Cited by 5,009
SCHULMAN, S., ANGERÅS, U., BERGQVIST, D., ERIKSSON, B., LASSEN, M. R., & FISHER, W. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03678.x · Cited by 3,756
Cerebrovascular disease in the community: results of a WHO collaborative study.
Aho, K., Harmsen, P., Hatano, S., Marquardsen, J., Smirnov, V. E., & Strasser, T. (1980) · Europe PMC (PubMed Central) · Cited by 1,310
Cervical-artery dissections: predisposing factors, diagnosis, and outcome
Debette, S., & Leys, D. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70084-5 · Cited by 833
(2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70018-9 · Cited by 503
Time Course of Symptoms in Extracranial Carotid Artery Dissections: A Series of 80 Patients
Biousse, V., D’Anglejan-Chatillon, J., Touboul, P.-J., Amarenco, P., & Bousser, M.-G. (1995) · Stroke · doi:10.1161/01.str.26.2.235 · Cited by 377
Cervical Arterial Dissection: Time for a Therapeutic Trial?
Beletsky, V., Nadareishvili, Z., Lynch, J., Shuaib, A., Woolfenden, A., & Norris, J. W. (2003) · Stroke · doi:10.1161/01.str.0000098649.39767.bc · Cited by 257
Self-citationAspirin vs anticoagulation in carotid artery dissection: A study of 298 patients
Georgiadis, D., Arnold, M., von Buedingen, H. C., Valko, P., Sarikaya, H., Rousson, V., Mattle, H. P., Bousser, M. G., & Baumgartner, R. W. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2a50a · Cited by 170
The CADISS Trial Investigators (2007) · International Journal of Stroke · doi:10.1111/j.1747-4949.2007.00165.x · Cited by 79
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Jia, S., Wang, M., Liu, Y., Gong, M., Jiang, W., & Zhang, H. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031542 · Cited by 6
Metadata
- Authors
- Markus, H. S., Levi, C., King, A., Madigan, J., Norris, J., & for the Cervical Artery Dissection in Stroke Study (CADISS) Investigators
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-06-01
- Volume
- 76
- Issue
- 6
- Pages
- 657
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2916927704
- Cited by
- 294
- References
- 9
- FWCI
- 22.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results. https://app.cochat.ai/papers/10.1001/jamaneurol.2019.0072
- The paper
- Markus, H. S., Levi, C., King, A., Madigan, J., Norris, J., & for the Cervical Artery Dissection in Stroke Study (CADISS) Investigators. (2019). Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2019.0072
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.